Ulcers Treatment in feet with diabetes diagnosis

Diabetes, with ulcerations on lower extremities which cannot easily heal, is the cause of more than a half of the amputations of lower extremities in the United States of America and in the risk group it is present at three percent of population. The risk of losing legs in the group of diabetic patients is about one percent a year in the world. According to the estimations of the World Health Organization, it is done about one million amputations a year, and every thirty seconds and so called great amputation of lower extremities for the reason of foot gangrene caused by diabetes. The previous ulcer (or amputation) after cured diabetic foot on one leg makes a predisposition, at the persons with diabetes, for reappearing the ulcer on the same of the other foot.
Cuba has developed a non-surgical treatment with excellent results:
Herberprot-P 75, Epidermal growth factor (FRE), human recombinant (h.rec)
Advantages of HEBERPROT-P when treatment of diabetic feet:

  • Accelerates healing of strong lesions with a syndrome of ischemic and neuropathic diabetic feet; 3 weeks were enough for granulation of affected spots with dimensions of 1 up to 80 cm2
  • Reduces a number of sanitations and surgical interferences;
  • Reduces risk of infections and superinfections of lower limb ulcers of patients with gangrene, what reduces a number of surgeries a lot;
  • Greatly improves patients’ quality life with trophic ulcers due to the fact of decrease of surgical interferences and prevents from recurrences;
  • Cut expenses on hospitalizing as a cost of treatment with HEBERPROT-P is much more lower than that of endovascular surgeries and there are no complications typical for surgery.
  • Competent treatment with the current drug is able to prevent from lower limb amputation. According to the tests made effect from the treatment starts in 2 weeks after beginning of the treatment (injection course)
    In accordance with clinic tests ulcers of 50% of patients, who have completed a treatment course with this drug, were completely treated and 79% of patients managed to avoid amputations.

Comments are closed.